Loading...
Loading...
OXINIUM Oxidized Zirconium, the patented advanced bearing material from Smith & Nephew
SNNSN Orthopaedics Division, has been awarded a C1 premium reimbursement classification in Japan for use in hip replacement surgery.
The decision by the Central Medical Insurance Committee comes three years after it awarded Smith & Nephew with Japan's first-ever premium price reimbursement for an orthopaedic implant—for the use of OXINIUM material in total knee replacement implants. Smith & Nephew is the only orthopaedic medical device company to have been awarded C1 reimbursement for both hip and knee replacement implants.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in